A top-tier programme of interviews and interactive debate led panel discussions at this year's Pharma Integrates will focus on the strategic issues facing the drug manufacturing sector.
Domainex's COO, Tom Mander will be on the panel for 'The Future of Biotech: Strategic Alliances and Innovative Outsourcing', which will consider how flexible and innovative outsourcing strategies enable rapid drug development, and how partnerships, strategic alliances and innovative collaborations have driven the biotech industry forward. Topics for debate include project enablement for biotech SMEs, the pros and cons of using multiple expert CROs and CDMOs, and the organisational and operational structures that biotechs should put in place to ensure their success and readiness to compete.
We are pleased to be able to offer a discount on standard delegate passes to a limited number of our guests. Get in touch if you would like to find out more or if you would like to meet with Tom at the conference.